Condition: Postpartum · VTE Prophylaxis · VTE (Venous Thromboembolism) · Sponsor: Thomas Jefferson University
The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.
This description comes directly from the study's public registry record.
Sophie H Green, MD · 215-955-5500 · sophie.green@jefferson.edu
Rupsa C Boelig, MD · 215-955-5500 · rupsa.boelig@jefferson.edu
Always discuss trial participation with your own doctor first.
| Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06831474